Aerpio Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ARPO and buy or sell other stocks, ETFs, and their options commission-free!About ARPO
Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes.
CEODavid Lennon, PhD
CEODavid Lennon, PhD
Employees40
Employees40
HeadquartersMorristown, New Jersey
HeadquartersMorristown, New Jersey
Founded2007
Founded2007
Employees40
Employees40
ARPO Key Statistics
Market cap83.42M
Market cap83.42M
Price-Earnings ratio17.82
Price-Earnings ratio17.82
Dividend yield—
Dividend yield—
Average volume183.98K
Average volume183.98K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.81
52 Week high$3.81
52 Week low$1.39
52 Week low$1.39
Stock Snapshot
As of today, Aerpio Pharmaceuticals(ARPO) shares are valued at $1.77. The company's market cap stands at 83.42M, with a P/E ratio of 17.82.
Aerpio Pharmaceuticals(ARPO) stock opened on 2026-01-01 at —. The price climbed to — and dipped to —.
The Aerpio Pharmaceuticals(ARPO)'s current trading volume is 0, compared to an average daily volume of 183.98K.
During the past year, Aerpio Pharmaceuticals(ARPO) stock moved between $1.39 at its lowest and $3.81 at its peak.
During the past year, Aerpio Pharmaceuticals(ARPO) stock moved between $1.39 at its lowest and $3.81 at its peak.
People also own
Based on the portfolios of people who own ARPO. This list is generated using Robinhood data, and it’s not a recommendation.